News Conference News ESC 2014 Mitral Regurgitation Associated with Decreased Survival in TAVR Patients Yael L. Maxwell September 03, 2014
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Conference News ESC 2014 APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI Yael L. Maxwell August 31, 2014
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
Presentation ESC 2013 Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial Presenter: Alvaro Avezum September 03, 2013
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013
News Conference News ESC 2013 Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib Yael L. Maxwell September 02, 2013
News Conference News ESC 2013 Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients Caitlin E. Cox September 02, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News ESC 2012 Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit Yael L. Maxwell August 29, 2012
News Conference News ESC 2012 WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants Yael L. Maxwell August 28, 2012
News Conference News ESC 2012 Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients Caitlin E. Cox August 27, 2012
News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012
News Conference News ESC Congress 2011: Drugs, Devices Work Together Caitlin E. Cox September 06, 2011